Skip to content
TrialScanner

NCT02909777

Trial of CUDC-907 in Children and Young Adults With Relapsed or Refractory Solid Tumors, CNS Tumors, or Lymphoma

Phase 1CompletedCRISCollaborator

Registry record

Lead sponsor
Dana-Farber Cancer Institute
Conditions
Lymphoma; Neuroblastoma; Brain Tumor; Solid Tumor
Primary completion
Dec 2025Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT02909777 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT02909777: Trial of CUDC-907 in... | TrialScanner